PSA - Quest Diagnostics - Substance Abuse Testing Services

Home Browse Search

SUBSTANCE ABUSE, TESTING SERVICES AGREEMENT This Agreement for company -sponsored substance abuse testing services (the "Agreement") is made effective as of the 1st day of September 2p17 by and between Quest Diagnostics Clinical Laboratories, Inc.("Quest Diagnostics") and CITY OF SOUTH BEND ("Purchaser"), and defines the services that Quest Diagnostics will provide Purchaser. 1. DESCRIPTION OF PROTOCOL. Quest Diagnostics will provide substance abuse testing of urine, oral fluid, blood, and/or hair specimens for Purchaser's substance abuse testing program at a Quest Diagnostics laboratory certified by the Substance Abuse and Mental Health Services Administration ("SAMHSA" ). 2. TEST ORDERS, SPECIMEN COLLECTION AND SPECIMEN TRANSPORTATION. 2.1 TEST ORDERS. Purchaser will ensure that all substance abuse testing is ordered by a person authorized by Purchaser pursuant to applicable law. 2.2 SPECIMEN COLLECTION. Collection of specimens shall be handled in the following manner: A) Purchaser may choose to refer applicantslemployees to Quest Diagnostics' Patient Service Centers ("PSCs") or Preferred Third Party Network Sites ("Preferred Collection Sites") for specimen collections at the additional charges outlined on Exhibit A; or B) Purchaser may choose to refer applicants/employees to non -preferred, third -party collection facilities, by separate arrangement and at such third -party collection fees as the parties shall negotiate. C) Purchaser may choose to perform specimen collections without the use of Quest Diagnostics or third party collection sites. (Section D applies only when Quest Diagnostics is responsible for Random Program Management) D) Quest Diagnostics agrees to perform the agreed -upon random program management services for Purchaser under the terms and at the additional charges outlined in Exhibit C of this Agreement. (Section E applies only when Quest Diagnostics is responsible for Collection management) E) Quest Diagnostics assumes full responsibility for the selection of third -party collection sites that are not a part of its Preferred Collection Site network and for payment of these non -preferred third -party collection fees. Fees outlined for management of collection services are outlined on Exhibit D of this Agreement. 2.3 SPECIMEN TRANSPORTATION. Specimen transportation costs are included in the Fees listed on Exhibit A. if alternate arrangements are made such that Purchaser assumes responsibility for transportation or shipping of specimens to Quest Diagnostics's laboratory, Purchaser must ensure that the specimens are placed in containers designed to minimize the possibility of damage during shipment and must be securely sealed. 3. RESULTS AVAILABILITY AND DELIVERY. 3.1 RESULTS AVAILABILITY. Quest Diagnostics will release the results of specimens that are negative on the initial (screening) test to the Medical Review Officer (WRO"), if applicable, or to Purchaser, typically within twenty-four (24) hours after receipt of the specimen at the testing site. Quest Diagnostics will release non -negative (e.g, positive) results (or those requiring recheck) to the MRO, if applicable, or to Purchaser's authorized contact, typically within forty-eight (48) to seventy-two (72) hours after receipt of the specimen at the testing site. When Purchaser utilizes the services of an MRO, Purchaser will comply with the provisions in Section 9. Holidays and weekend work schedules or specimens requiring clarification by the Purchaser or collector may alter the schedule of results availability described above. 3.2 RESULTS DELIVERY. Results will be returned to a recipient designated by Purchaser according to a procedure agreed upon by Purchaser and